More of the same, page-2

Given the time frame to get TT-034 approved, ~8 years with an unknown patient population they really need to be held accountable for not moving the other other programs past the "discovery" and "pre-clinical" stages. The arrows haven't budged since I invested in January.

I know this has been discussed before but it's even more frustrating to me than the delays of the ongoing (sort of) Hep C trial. What in the heck are these people doing all day because it sure as hell appears it isn't working toward the future. Time for another email that will be ignored. Am i being ignorant here in expecting action on these other programs?